In addition, among the seven cytokines determined in the plasma, IL-6 was significantly higher in patients with stage III HCC patients than stage I HCC patients (P<0.001), whereas the other cytokines were below the level of sensitivity for detection of the CBA kit in most samples (Table S2). Here, IL6 is linked to hepatocellular carcinoma.